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SUPPLEMENTARY INFORMATION 
 
Supplementary Note 
 
SMER3 prevents the assembly of SCFMet30 or induces SCF complex dissociation.  
Presently we are unable to distinguish between these two possible modes of action by 
SMER3.  Attempts to detect SMER3-dependent release of Met30 from the SCF complex 
in vitro were unsuccessful.  Furthermore, complex assembly cannot be studied in vitro 
since Met30 expressed without Skp1 is unstable and does not assemble with the 
purified Cdc53/Skp1 complex.  Nevertheless, the fact that SMER3 inhibits SCFMet30 
ubiquitin E3 ligase activity in vitro and causes dissociation of Met30 from Skp1 in vivo 
suggests that SMER3 changes the binding characteristics of Met30 to Skp1, whereby 
ligase activity is inhibited in vitro, but also leads to disassembly in vivo.  
 
Destabilization of non-target proteins in DARTS.  We found that whereas SMER3 
binding protects the F-box region of Met30 (but not Cdc4) from protease digestion, the 
WD-40 repeat domain of Met30 is rendered more susceptible to protease digestion in 
the presence of SMER3. We have also observed this destabilization of non-target 
proteins involving other small molecules. A most striking example is shown below, 
which involves a well-studied small molecule-protein pair. In this case, rapamycin 
destabilizes a rapamycin-resistant point mutant of mTOR that cannot bind rapamycin, 
whereas the wild type mTOR protein is expectedly stabilized by rapamycin.   
 
 
Discussion about the link between TOR and SCFMet30.  Since TOR inhibition does 
not result in accumulation of deubiquitinated Met4, the genetic interaction between TOR 
and SCFMet30 must be occurring downstream of this event.  There are a number of 
viable hypotheses that can explain our observations.  One such hypothesis simply ties 
the two pathways together based on their convergence on regulation of the G1 cyclins.  
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Inhibition of SCFMet30 by SMER3 results in activation of Met4 and, consequently, down-
regulation of CLN1 and CLN2 (ref 14).  This is also evident from our gene expression 
profiling experiments in which expression of the G1 cyclins is seen to be down-
regulated upon SMER3 treatment (Supplementary Table 2).  Similarly, rapamycin 
treatment also results in down-regulation of CLN1 and CLN2 (ref 24).  Another 
hypothesis, which is not necessarily incongruent with the above, involves a transcription 
regulatory protein called VDE.  VDE has been shown to localize to the nucleus upon 
TOR inhibition (in a manner similar to that of a well-known TOR-regulated transcription 
factor, Gln3) 31 and regulate a number of genes involved in sulfur metabolism during 
sulfur starvation 32, 33.  In fact, one such gene example, CYS3, is largely regulated by 
the Met4 transcription complex, yet VDE binding is shown to enhance gene expression.  
Furthermore, a number of MET genes (that are regulated by Met4) contain the 5’ UTR 
consensus sequence shown to bind VDE.  This hypothesis is very interesting (though it 
remains to be substantiated) since it suggests that while there is a separate response 
for sulfur starvation from TOR inhibition (including, carbon and/or nitrogen starvation), 
TOR inhibition can enhance this response through nuclear localization of VDE, resulting 
in the co-regulation of genes (i.e. genes that result in down-regulation of the G1 cyclins) 
during times of nutrient depletion. 
 
Yeast strains and media. Yeast strains used in this study are listed below. Cells were 
grown in standard YPD (yeast extract-peptone-dextrose), YPDA (YPD+adenine), or SD 
(synthetic dextrose) dropout media lacking the appropriate amino acid as indicated. 
Standard protocols for yeast genetics and molecular biology were used 34. 
 
Strain Relevant Genotype Source or 
Reference 
BY4741 MATa his31 leu20 met150 ura30 35, 36 
met4 As BY4741 but met4::kanMX4 this study 
PY1 MATa bar1 ura3ns ade1 his2 leu2-3,112 trp1-1a 37 
cdc4-3 (PY187) As PY1 but cdc4-3 38 
cdc34-3 (PY24) As PY1 but cdc34-3 38 
cdc53-1 (PY175) As PY1 but cdc53-1  38 
met4 (PY544) As PY1 but met4::KAN 39 
met30-6 (PY283) As PY1 but met30-6::KAN 39 
met30-9 (PY281) As PY1 but met30-9::KAN 38 
skp1-25 (PY1374) As PY1 but skp1-25-YCp::TRP1 skp1::KAN this study 
13Myc-MET30 SKP1-HA 
(PY1277) 
As PY1 but 13MycMET30::ZEO SKP1HA::KAN 
pep4::URA3 
this study 
HBTH-SKP1 (PY1822) 
 
As PY1 but 
HBTHSKP1 lys2::ZEO arg4::HYG 
pep4::KAN 
this study 
 
GAL1-SKP1 (PY204) As PY1 but SKP1-YIpG2::LEU2 skp1::KAN this study 
GAL1-MET30-RGS6H 
(PY162) 
As PY1 but MET30RGS6H-YIpG2::LEU2::TRP1 
met30::KAN 
this study 
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Supplementary Figures 
 
 
 
Supplementary Figure 1. Synthetic sick/lethal interactions between SMER3 and 
rapamycin, where cells treated with both molecules display more severe fitness defects 
than cells treated with either molecule alone. BY4741 cells (4 x 105 cells/ml) were 
treated with SMERs serially diluted 2-fold from 50 M to 3.125 M in the presence and 
absence of 50 nM rapamycin. The plate was imaged 2 days post-treatment.  
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Supplementary Figure 2. Growth curve analysis of SMER3 resistance in met4 cells. 
The numbers in green indicate SMER3 or rapamycin concentrations in each well. Three 
independent colonies were used in this experiment. 
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Supplementary Figure 3.  SMER3, but not SMER1, inhibits SCFMet30 E3 ligase in vitro. 
Components of SCFMet30 were co-expressed in insect cells and the complex was 
purified based on a GST-tag fused to Skp1. Met4 expressed in insect cells was bound 
to SCFMet30 and the ligase-substrate complex was eluted with glutathione. Purified 
ligase-substrate complexes were pre-incubated with DMSO or the indicated 
concentrations of SMER1 or SMER3 for 15 min before the ubiquitination reaction was 
initiated by addition of a final concentration of 250 nM yeast E1 (Boston Biochem, #E-
301), 4 M recombinant Cdc34 purified from E. coli 46, 5 mM ATP, and 80 M ubiquitin 
(Sigma, #U6253). The reaction was allowed to proceed for 60 minutes and reaction 
products were analyzed by immunoblotting with anti-Met4 antibody. The asterisk (*) 
indicates Met30, which cross-reacts with the anti-Met4 antibody.  
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Supplementary Figure 4. Total Met30 protein levels were unaffected after treatment of 
cells with 20 M SMER3 for 30min. Quantitation was done on a Fuji LAS4000 imaging 
system. Samples were normalized to the proteasome subunit Rpt1. 1x and 2x indicates 
total amounts of lysates loaded on the gel. 
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Supplementary Figure 5.  Quantitative western analysis of Figure 4d showing that 
Met30 is protected against thermolysin digestion by SMER3.  Intensities of samples that 
were digested for 10 min with thermolysin were normalized to those of undigested 
samples. 
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Supplementary Figure 6.  SMER3 protects the F-box region, but not the WD40-repeat 
region, of recombinant Met30 from protease digestion.  Met30 coding region 1-870 (F-
box) or 871-1923 (WD-40 repeat) was PCR-subcloned into pcDNA3.1(-) (Invitrogen).  
Proteins were expressed using Promega TnT T7 Quick Coupled 
Transcription/Translation System.  Thermolysin digestion was performed using 
translated lysate incubated with SMER3 or vehicle control, and stopped by adding 
EDTA pH 8.0.  Samples were subjected to 4-12% NuPAGE gradient gel (Invitrogen) 
and Western blotted with anti-RGSH (Qiagen) and anti-GAPDH (Ambion) antibodies. 
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Supplementary Figure 7.  SMER3 protects recombinant Met30 F-box region, but not 
Cdc4 F-box region, from protease digestion. Met30 coding region 1-870 (F-box) and 
Cdc4 coding region 1-1020 (F-box) were each PCR-subcloned into pcDNA3.1(-) 
(Invitrogen). Proteins were expressed using Promega TnT T7 Quick Coupled 
Transcription/Translation System. Thermolysin digestion was performed using 
translated lysate incubated with SMER3 or vehicle control, and stopped by adding 
EDTA pH 8.0. Samples were subjected to 4-12% NuPAGE gradient gel (Invitrogen) and 
Western blotted with anti-RGSH (Qiagen) and anti-GAPDH (Ambion) antibodies. The 
asterisks (*) indicate the Fbox(Met30) fragments that are protected by SMER3 from 
protease digestion. 
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Supplementary Figure 8.  Full-length blots for figure 3a,e-f. 
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Supplementary Table 1. GO biological process terms enriched among the up-regulated vs. down-regulated 
clusters of SMER3 specific genes. p-value cutoff <0.01. 
 
 
 
SMER3 GOID GO_term
Expected 
Gene #
Observed 
Gene #
Cluster 
Gene #
GO_term 
Gene #
Genome 
Gene #
P-value
42221 response to chemical stimulus 16 40 279 404 7159 9.96E-06
9636 response to toxin 1 9 279 29 7159 0.00029
42493 response to drug 5 17 279 127 7159 0.00236
6790 sulfur metabolic process 3 12 279 71 7159 0.00496
51726 regulation of cell cycle 2 9 68 158 7159 0.00269
79 regulation of cyclin-dependent protein kinase activity 0 4 68 19 7159 0.00435
Up-
regulated 
Down-
regulated
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Supplementary Table 2. Expression of MET-genes and cell cycle genes in cells 
exposed to SMER3. 
 
Gene Name      Fold change Description 
      Sulfur metabolism 
MET1 6.1 S-adenosyl-L-methionine uroporphyrinogen III transmethylase 
MET2 9.5 L-homoserine-O-acetyltransferase 
MET3 4.7 ATP sulfurylase 
MET10 1.8 Subunit alpha of assimilatory sulfite reductase 
MET14 2.7 Adenylylsulfate kinase 
MET16 7.1 3'-phosphoadenylsulfate reductase 
MET28 10.5 Transcriptional activator in the Cbf1p-Met4p-Met28p complex 
MET32 11.6 Zinc-finger DNA-binding protein 
ECM17/MET5 2.3 Sulfite reductase beta subunit 
      Permeases 
SUL1 4.0 High affinity sulfate permease 
SUL2 3.8 High affinity sulfate permease 
MUP1 1.8 High affinity methionine permease  
MUP3 8.8 Low affinity methionine permease 
      Cell cycle 
CLN1 -2.7 G1 cyclin involved in regulation of the cell cycle 
CLN3 -2.5 G1 cyclin involved in cell cycle progression 
CLB1 -2.3 B-type cyclin involved in cell cycle progression 
CLB2 -5.9 B-type cyclin involved in cell cycle progression 
CLB3 -2.0 B-type cyclin involved in cell cycle progression 
CLB5 -1.9 B-type cyclin involved in DNA replication during S phase 
CLB6 -2.1 B-type cyclin involved in DNA replication during S phase 
HCM1 -3.3 Forkhead transcription factor that drives S-phase specific expression 
MCM10 -2.1 
Essential chromatin-associated protein involved in the initiation of 
DNA replication 
CDC6 -4.0 Essential ATP-binding protein required for DNA replication 
BUR2 -2.5 Cyclin for the Sgv1p (Bur1p) protein kinase 
WHI5 -2.6 
Repressor of G1 transcription that binds to SBF at SCB target 
promoters in early G1 
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